NCT03547739

Brief Summary

This study will test the efficacy and cost-effectiveness of an interdependence theory-based couples intervention in Kenya that reaches pregnant women and male partners through home visits by male-female pairs of lay health workers, and includes offer of home-based CHTC services.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1,600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 9, 2018

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 6, 2018

Completed
10 months until next milestone

Study Start

First participant enrolled

March 20, 2019

Completed
5.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 27, 2024

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 23, 2024

Completed
11 months until next milestone

Results Posted

Study results publicly available

September 26, 2025

Completed
Last Updated

September 26, 2025

Status Verified

July 1, 2025

Enrollment Period

5.3 years

First QC Date

May 9, 2018

Results QC Date

June 20, 2025

Last Update Submit

September 5, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of Couples Who Tested for HIV as a Couple After Study Enrollment up to 12 Months Postpartum

    Number of couples with couple HIV testing uptake during observation period (from baseline to 12 months postpartum), coded as Y=if the couple tested together for HIV up to 12 months postpartum and N=if the couple has not tested together for HIV up to 12 months postpartum. At 3 and 12 months postpartum, each couple member was asked to report whether they had tested together for HIV as a couple at home with HIV self-test kits or at the clinic.

    up to 12 months postpartum

Secondary Outcomes (18)

  • HIV Re-testing

    Up to 12 months postpartum

  • Number of New Male HIV-positive Diagnoses From Baseline up to 12 Months Postpartum (Intervention Arms Only)

    Up to 12 months postpartum

  • Number of New Discordant Couples (Intervention Arms Only)

    Up to 12 months postpartum

  • HIV+ Women Who Utilized All 3 PMTCT Interventions up to 18 Months Postpartum

    Up to 18 months postpartum

  • Women Who Utilized All 4 MCH Services up to 3 Months Postpartum

    Up to 3 months postpartum

  • +13 more secondary outcomes

Study Arms (3)

Home visits

ACTIVE COMPARATOR

Participants randomized to intervention arm receive 5 home visits conducted by one female and one male lay health worker.

Behavioral: Home visits

HIV Self-testing

ACTIVE COMPARATOR

Women in this study group will receive HIV self-test kits for themselves and their male partner at up to 4 time points.

Behavioral: HIV Self-testing

Standard Care

NO INTERVENTION

Participants will receive current standard clinic-based services including the option for women and partners to return to the clinic for male partner HIV testing or Couples HIV Counseling and Testing (CHCT).

Interventions

Home visitsBEHAVIORAL

If a couple has been randomized to the home visit intervention arm, a lay health worker will obtain detailed locator information (including cell phone contacts) and consult with the couple about optimal times for a home visit. As described above, the intervention arm will consist of five home visits conducted by one female and one male lay health worker, including two home visits during pregnancy, one at six weeks after the birth, and two booster sessions, one at six months after the birth and one at 12 months after the birth. Home visits are designed for all pregnant couples (regardless of woman's initial HIV test result at the antenatal clinic) and include topics important for maternal, paternal, and child health during pregnancy and postpartum.

Home visits

Women in this study group will receive oral-fluid-based rapid HIV test kits for themselves and their male partner at up to 4 time points (twice during pregnancy and twice postpartum). Each test will be accompanied with a self-testing instruction sheet describing step-by-step procedures in multiple languages. Study staff will also conduct a brief demonstration on how to use the tests. Participants will be encouraged to offer a test kit to their male partner or to undertake couples testing. They will also be counseled on how to talk to their partners and the possibility of adverse partner reactions. Participants will be instructed to seek clinic-based confirmatory testing if a reactive self-test result is obtained.

HIV Self-testing

Eligibility Criteria

Age15 Years+
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Women at 36 weeks of pregnancy or less
  • years of age or older
  • Has been offered HIV testing at ANC
  • Is currently in a stable relationship with a male partner and living with that male partner - Has not yet participated in couple HIV testing during this pregnancy.
  • Male partner is the person identified by the pregnant woman as her primary male partner and should also be 15 years of age or older.
  • Not in an HIV-positive concordant relationship.

You may not qualify if:

  • Greater than 36 weeks of pregnancy
  • Less than 15 years of age
  • Not currently in a stable relationship with a male partner
  • Does not currently live with male partner
  • Has not been offered HIV testing at ANC

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kenya Medical Research Institute

Nairobi, Kenya

Location

Related Publications (2)

  • Kwena Z, Kimbo L, Darbes LA, Hatcher AM, Helova A, Owino G, Thirumurthy H, Bukusi EA, Braun T, Kilgore M, Pisu M, Tamhane A, Nghiem VT, Agot K, Neilands TB, Turan JM. Testing strategies for couple engagement in prevention of mother-to-child transmission of HIV and family health in Kenya: study protocol for a randomized controlled trial. Trials. 2021 Jan 6;22(1):19. doi: 10.1186/s13063-020-04956-1.

  • Borgstede SJ, Elly A, Helova A, Kwena Z, Darbes LA, Hatcher A, Thirumurthy H, Owino G, Pisu M, Owuor K, Braun T, Turan JM, Bukusi EA, Nghiem VT. Cost of Home-Based Couples Human Immunodeficiency Virus Counseling and Testing and Human Immunodeficiency Virus Self-Testing During Pregnancy and Postpartum in Southwestern Kenya. Value Health Reg Issues. 2023 Mar;34:125-132. doi: 10.1016/j.vhri.2022.11.003. Epub 2023 Jan 27.

MeSH Terms

Conditions

Acquired Immunodeficiency Syndrome

Interventions

House Calls

Condition Hierarchy (Ancestors)

HIV InfectionsBlood-Borne InfectionsCommunicable DiseasesInfectionsSexually Transmitted Diseases, ViralSexually Transmitted DiseasesLentivirus InfectionsRetroviridae InfectionsRNA Virus InfectionsVirus DiseasesSlow Virus DiseasesGenital DiseasesUrogenital DiseasesImmunologic Deficiency SyndromesImmune System Diseases

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Limitations and Caveats

Investigators enrolled a selected sample of couples who were living together in stable relationships with both partners of the couple willing to participate in the research. The study used self-report measures for the primary outcome of CHTC for the comparison groups and several of the intermediate variables, which may be subject to recall and other reporting biases. Another limitation was introduced by the occurrence of the COVID-19 pandemic in the middle of the study period.

Results Point of Contact

Title
Janet M. Turan, PhD, MPH
Organization
University of Alabama at Birmingham

Study Officials

  • Janet M Turan, PhD, MPH

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR
  • Lynae Darbes, PhD

    University of Michigan

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 9, 2018

First Posted

June 6, 2018

Study Start

March 20, 2019

Primary Completion

June 27, 2024

Study Completion

October 23, 2024

Last Updated

September 26, 2025

Results First Posted

September 26, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations